Brian Freeman/LinkedIn
Aug 21, 2026, 08:32
Brian Freeman: Supporting Innovation in Rare Blood Disorders
Brian Freeman, Sr Manager, Leadership Search and Scouting at Sanofi, shared a post on LinkedIn:
“While a rare blood disorder diagnosis can reshape the path ahead, it doesn’t define what’s possible.
At Sanofi, we’re committed to advancing research and supporting scientific innovation to help create more possibilities for the rare blood disorders community.
This starts with listening to people living with hemophilia and immune thrombocytopenia (ITP) to understand their unique needs, and using those insights to help shape progress for the rare blood disorders community.
Hear patient perspectives, discover resources, and learn more about rare blood disorders.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida
-
Aug 21, 2026, 10:23Salvador Payán Pernía: Tailoring Therapy in Sickle Cell Disease – Mitapivat and the Path Toward Personalized Combination Care
-
Aug 21, 2026, 10:10Pete Stibbs: The Evolving Landscape of VTE Management
-
Aug 21, 2026, 09:58Nishant K Mishra։ When Epilepsy Meets Anticoagulation
-
Aug 21, 2026, 09:07Sujal Lohana: Building a Better Blood Donor–Seeker App
-
Aug 21, 2026, 08:55Robert Sidonio: Connecting Experts in Bleeding and Clotting Disorders